Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are at least 18 years old at the time of receiving the device implant
- People who have moderate to severe obstructive sleep apnoea, meaning their breathing interruptions during sleep fall within a specific measured range (between 15 and 65 events per hour)
- People who have tried and not been able to use, or are not suitable for, CPAP (a breathing machine used during sleep) and/or a mandibular advancement device (a mouth device worn during sleep)
- People who have had a specific sleep-related airway assessment (called Drug-Induced Sleep Endoscopy, or DISE) showing that a particular type of airway collapse is not present
- People who have already received the Inspire hypoglossal nerve stimulation (HNS) device, or are receiving it, and are able to give their informed consent to participate
Who may not be able to join:
- People with a Body Mass Index (BMI) above 32 kg/m² (a measure of body weight relative to height)
- People whose sleep apnoea events are made up of more than 25% mixed or central type breathing interruptions (rather than the obstructive type)
- People who, during the DISE assessment, show a specific pattern of airway collapse at the soft palate, or have any other structural airway feature that could prevent the device from working properly
- People who have severely reduced nerve-related control over the muscles in the upper airway
- People who are pregnant
- People who have had surgery on the soft palate within the three months before the implant procedure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Olivier Vanderveken, MD, PhD, University Hospital, Antwerp
Phone: +3238215780
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Delta apnea-hypopnea index (AHI) as measured by a polysomnography
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.